PharmaJet announces Quadrivalent Influenza Vaccine for Needle-free delivery begins shipping for 2017-18 flu season
Quadrivalent and Trivalent influenza vaccines now available with Needle-free delivery
GOLDEN, Colo., Aug. 29, 2017 /PRNewswire/ -- PharmaJet® Inc., the maker of needle-free injection technology, today announced that shipping has begun for the quadrivalent influenza vaccine for needle-free delivery with the PharmaJet Stratis® device for the 2017-18 influenza season.
"Adding a quadrivalent influenza vaccine to the already available trivalent vaccine offering with our Needle-free delivery means healthcare providers and patients now have a choice of vaccines for the upcoming flu season," said Ron Lowy, PharmaJet Chairman and CEO. "Not only does Needle-free offer an alternative for those 25% of adults that fear needles(1), but it also gives pharmacies and flu clinic providers a way to differentiate their flu immunization program, and a way to drive increased immunization rates and store traffic."
PharmaJet offers the only Needle-free delivery system cleared by the FDA for administration of inactivated influenza vaccines.
Refer to Instructions for Use to ensure safe injections and to review risks. |
|
(1) |
Survey of the prevalence of immunization non-compliance due to needle fears in children and adults." Taddio A, Ipp M, Thivakaran S, et al. Vaccine 2012; 30;4807-4812 Web. https://dx.doi.org/10.1016/j.vaccine.2012.05.011 |
About PharmaJet
Based in Golden, Colorado, PharmaJet's mission is worldwide acceptance of PharmaJet needle-free devices as a standard of care in the vaccine delivery market. PharmaJet's devices are also integral in the development of multiple novel pharmaceuticals. The innovative Stratis® device has U.S. FDA 510(k) marketing clearance, CE Mark and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. In August 2014, the PharmaJet Stratis® device was cleared for delivery of an influenza vaccine to deliver needle-free flu shots. The Tropis® device for intradermal injections received authorization to apply the CE Mark in May 2016. The PharmaJet Needle-free devices are safe, fast and easy-to-use. They eliminate needlestick injuries, needle reuse and cross contamination, and help reduce sharps waste disposal. For more information, visit www.pharmajet.com.
CONTACT:
Nancy Lillie
[email protected]
1-888-900-4321 Option 3
SOURCE PharmaJet
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article